Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Levofloxacin decreased chest wall mechanical inhomogeneities and airway and vascular remodeling in rats with induced hepatopulmonary syndrome.

Gaio E, Amado V, Rangel L, Huang W, Storck R, Melo-Silva CA.

Respir Physiol Neurobiol. 2013 Dec 1;189(3):565-70. doi: 10.1016/j.resp.2013.08.006. Epub 2013 Aug 28.

PMID:
23994178
2.

Respiratory mechanics and lung tissue remodeling in a hepatopulmonary syndrome rat model.

Melo-Silva CA, Gaio E, Trevizoli JE, Souza CS, Gonçalves AS, Sousa GC, Takano G, Tavares P, Amado VM.

Respir Physiol Neurobiol. 2011 Dec 15;179(2-3):326-33. doi: 10.1016/j.resp.2011.10.001. Epub 2011 Oct 8.

PMID:
22005255
3.

Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome.

Rabiller A, Nunes H, Lebrec D, Tazi KA, Wartski M, Dulmet E, Libert JM, Mougeot C, Moreau R, Mazmanian M, Humbert M, Hervé P.

Am J Respir Crit Care Med. 2002 Aug 15;166(4):514-7.

PMID:
12186830
4.

TNF-α neutralization improves experimental hepatopulmonary syndrome in rats.

Liu L, Liu N, Zhao Z, Liu J, Feng Y, Jiang H, Han D.

Liver Int. 2012 Jul;32(6):1018-26. doi: 10.1111/j.1478-3231.2012.02821.x.

PMID:
22672643
5.

Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats.

Nunes H, Lebrec D, Mazmanian M, Capron F, Heller J, Tazi KA, Zerbib E, Dulmet E, Moreau R, Dinh-Xuan AT, Simonneau G, Hervé P.

Am J Respir Crit Care Med. 2001 Sep 1;164(5):879-85.

PMID:
11549549
6.

Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Zhang J, Fallon MB.

Nat Rev Gastroenterol Hepatol. 2012 Sep;9(9):539-49. doi: 10.1038/nrgastro.2012.123. Epub 2012 Jul 3. Review.

PMID:
22751459
7.

Glucose-regulated protein 78 may play a crucial role in promoting the pulmonary microvascular remodeling in a rat model of hepatopulmonary syndrome.

Zhang H, Lv M, Zhao Z, Jia J, Zhang L, Xiao P, Wang L, Li C, Ji J, Tian X, Li X, Fan Y, Lai L, Liu Y, Li B, Zhang C, Liu M, Guo J, Han D, Ji C.

Gene. 2014 Jul 15;545(1):156-62. doi: 10.1016/j.gene.2014.04.041. Epub 2014 Apr 21.

8.

A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.

Thenappan T, Goel A, Marsboom G, Fang YH, Toth PT, Zhang HJ, Kajimoto H, Hong Z, Paul J, Wietholt C, Pogoriler J, Piao L, Rehman J, Archer SL.

Am J Respir Crit Care Med. 2011 Apr 15;183(8):1080-91. doi: 10.1164/rccm.201008-1303OC. Epub 2010 Dec 10.

9.

Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats.

Zhang J, Ling Y, Tang L, Luo B, Pollock DM, Fallon MB.

Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G704-8. doi: 10.1152/ajpgi.90627.2008. Epub 2009 Feb 5.

10.

[Reduction of endotoxin may protect lung from injury in rats with hepatopulmonary syndrome].

Wang WB, Jia CK, Liang L.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 May;36(3):285-90. Chinese.

PMID:
17571313
12.

The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat.

Ling Y, Zhang J, Luo B, Song D, Liu L, Tang L, Stockard CR, Grizzle WE, Ku DD, Fallon MB.

Hepatology. 2004 Jun;39(6):1593-602.

PMID:
15185300
13.

[Experimental models for assessment of pulmonary alterations in hepatopulmonary syndrome].

Vercelino R, Tieppo J, Forgiarini Junior LA, Dias AS, Marroni CA, Marroni NP.

J Bras Pneumol. 2008 Jul;34(7):453-60. Portuguese.

14.

The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.

Zhang J, Yang W, Luo B, Hu B, Maheshwari A, Fallon MB.

J Hepatol. 2012 Oct;57(4):752-8. doi: 10.1016/j.jhep.2012.05.014. Epub 2012 May 29.

15.

Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.

Chang CC, Chuang CL, Lee FY, Wang SS, Lin HC, Huang HC, Teng TH, Hsu SJ, Hsieh HG, Lee SD.

Clin Sci (Lond). 2013 Apr;124(7):457-66. doi: 10.1042/CS20120052.

PMID:
23043394
16.

Effects of undernutrition on respiratory mechanics and lung parenchyma remodeling.

Dias CM, Pássaro CP, Cagido VR, Einicker-Lamas M, Lowe J, Negri EM, Capelozzi VL, Zin WA, Rocco PR.

J Appl Physiol (1985). 2004 Nov;97(5):1888-96. Epub 2004 Jun 11.

17.

Effect of annexin A2 on hepatopulmonary syndrome rat serum-induced proliferation of pulmonary arterial smooth muscle cells.

Zeng J, Yi B, Wang Z, Ning J, Wang X, Lu K.

Respir Physiol Neurobiol. 2013 Jan 15;185(2):332-8. doi: 10.1016/j.resp.2012.09.009. Epub 2012 Oct 8.

PMID:
23059374
18.

Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment.

Grace JA, Angus PW.

J Gastroenterol Hepatol. 2013 Feb;28(2):213-9. doi: 10.1111/jgh.12061. Review.

PMID:
23190201
19.

Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia.

Zhang HY, Han DW, Zhao ZF, Liu MS, Wu YJ, Chen XM, Ji C.

World J Gastroenterol. 2007 Jul 7;13(25):3500-7.

20.

Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome.

Zhang M, Luo B, Chen SJ, Abrams GA, Fallon MB.

Am J Physiol. 1999 Nov;277(5 Pt 1):G944-52.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk